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Noise and sports events
To the Editor: I read the recent article on sound exposure 
during football matches in the SAMJ with great interest.1 
Swanepoel et al. concluded that ‘exposure levels exceeded 
limits of permissible average and peak sound’1 and ‘Public 
awareness and personal hearing protection should be 
prioritised as preventive measures’.1 It is interesting that sound 
from sports competitions could be an important forgotten 
noise. Indeed, sport noise-induced deafness has been proposed 
for years.2 The control of noise from competitions (e.g. control 
of audiovisual facilities) might be required; this would be more 
appropriate than having the spectators use protective devices.
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Health technology assessment – a new 
initiative in South Africa
To the Editor: From a clinical perspective, technology is 
expected to reduce the risk of disease, reduce duration of 
illness, improve quality of care, increase access and restore, 
or limit the decay of, a person’s quality of life. Technology 
is also expected to contain costs and improve interventional 
risk management through enhancement of service efficiency 
and productivity of health care professionals. As health 
technology evolves, so does the need to assess its impact on 
patients’ health outcomes, hospital operations, and financial 
resources. This process leads to the evolution of health 
technology assessment (HTA), which is a systematic evaluation 
of properties, effects and other consequences of health care 
technology. Its purpose is to provide objective information 
for supporting health care decisions and policy-making at 
international, national, provincial and health facility levels. An 
effective HTA programme produces good-quality information 
and analysis, and then effectively uses this information 
and knowledge to influence decision-makers in health care 
systems.1
The South African National Department of Health (DoH) 
published a policy paper on HTA in 1997. A steering committee 
was formed to drive the HTA agenda in South Africa, and a 
regulatory framework has been established under the National 
Health Act (Act No. 61 of 2003). Since then, little has been 
achieved in this field, although the importance of HTA was 
highlighted 10 years ago.2 Currently, only two universities in 
the country offer formal HTA programmes.
Against this backdrop, the Clinical Epidemiology Unit of the 
University of the Witwatersrand has initiated a translational 
research project to introduce HTA to public hospitals in South 
Africa. These hospitals spend a significant amount of resources, 
and there is an urgent need to develop their evidence-
based decision-making processes in view of the impending 
introduction of national health insurance. The unit has 
established links with international organisations involved with 
HTA to create best practices in this field.
The unit has been working with several public hospitals’ 
chief executive officers, who have been conducting research 
for their master’s degrees in hospital management. Their 
areas of research include various components of HTA such 
as assessment of medical equipment, pharmaceuticals, blood 
and blood products, practice of clinical procedures, clinical 
governance and risk assessment (Fig. 1). These reports will be 
submitted to the national and provincial departments of health 
for the purposes of improving service delivery in South Africa’s 
public hospitals.
Moreshnee Govender
School of Public Health
University of the Witwatersrand
Johannesburg and
Warmbaths Hospital
Motlatso Elias Letshokgohla
School of Public Health
University of the Witwatersrand
Debashis Basu
Department of Community Health
University of the Witwatersrand and
Charlotte Maxeke Johannesburg Hospital
Debashis.Basu@wits.ac.za
1.    International Network of Agencies for Health Technology Assessment. A Checklist for Health 
Technology Assessment Reports, 2001. http://www.inahta.org (accessed 12 March 2010).
2.    Kachieng’a MO, Boonzaier DA. Health care technology assessment – the South African health 
care system in transition. S Afr Med J 1999; 89(2): 149-155.
Clinical haematology training in South 
Africa for Fellows with the primary  
specialty of Internal Medicine – what’s 
in a name?
To the Editor: Clarity with regard to what training in clinical 
haematology in South Africa involves and aims to achieve can 
be elusive. Clinical haematology trainees can have primary 
specialties of Internal Medicine or Paediatrics or Pathology 
(Haematology). I discuss the situation of those with the 
primary specialty of Internal Medicine. 
 
 
Fig. 1. Various components of health technology assessments currently studied in South 
African public hospitals. 
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Fig. 1. Various components of health technology assessments currently 
studied in South African public hospitals.
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In South Africa, clinical haematology combines clinical and 
laboratory haematology into one subspecialty. Regulation 
11(1) of Government Notice No. R.590 of 29 June 2001 
(Government Notice)1 states that a clinical haematologist shall 
have completed 4 years of training as a registrar in Medicine 
and then 2 years in Pathology (Haematological). In practice, 
interpretations vary. 
The Clinical Haematology regulations of the College of 
Physicians2 agree with the Government Notice1 on who is a 
clinical haematologist (CH). However, the regulations stipulate 
a clinical training component of 1 year and a laboratory 
training component of a minimum duration of 1 year, which 
differs from the apparent requirement of 2 years’ training in the 
laboratory component. The regulations state that a CH should 
restrict himself/herself to treating adults with haematological 
disorders and can perform laboratory investigations within 
the scope of his/her training. The word ‘restrict’ may be 
interpreted to mean that the CH should restrict himself/
herself to adult patients rather than paediatric patients, or that 
a CH should restrict himself/herself to the clinical component 
of haematology. In contrast, the regulations for pathologists3 
stick to the Government Notice and stipulate a 2-year clinical 
training component in either paediatrics or internal medicine. 
This makes the training and practice of clinical haematology 
for haematopathologists straightforward.
The regulations of the College of Physicians offer two 
possible interpretations to the training for clinical haematology, 
exemplified by the definitions of a haematologist in the 
USA and the UK. According to the American Society of 
Hematology (ASH), ‘a hematologist is a physician who 
specializes in the diagnosis, treatment, prevention, and/or 
investigation of disorders of the hematopoietic, hemostatic, and 
lymphatic systems, and disorders of the interaction between 
blood and blood vessel wall’.4 The ASH therefore defines 
two types of haematologists: doctors who specialise in the 
clinical and laboratory aspects of haematology, and doctors 
who specialise in laboratory aspects. The ASH curriculum4 
is intended for the former group but does not emphasise 
practical competency in laboratory haematology, which it 
presumably leaves to pathologists.5 The European Hematology 
Association (EHA), while maintaining the ASH definition 
of haematology, emphasises that a haematologist should 
have both clinical and technical laboratory competences6 
and defines technical competence as the ability to carry out 
specific laboratory tests independently. However, the EHA 
acknowledges that European countries vary in terms of the 
profile and definition of a haematologist, with some countries 
considering haematopathology as part of haematology and 
others considering it a different specialisation.6 In the UK 
haematopathology is part of haematology and is not a separate 
specialisation.7
Some training institutions in South Africa may interpret 
clinical haematology according to the ASH and others may 
interpret it along the UK lines. The former institutions may 
believe that the 1 year of laboratory training in clinical 
haematology is not enough for physicians to achieve the 
competencies of a haematopathologist, while the latter 
institutions may provide physician clinical haematology 
trainees with laboratory rotations that provide graduated 
responsibilities including laboratory medicine calls.
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